#Amides Amide Bond Activation: Concepts and Reactions edited by @Szostak_Group, is now online. Check it out for the latest on #amide#bonds.
https://t.co/URltsUTJYB
Late-stage skeletal editing of peptide −SS− bonds through bis-dehydroalanine intermediates provides ready access to chemically unique −CC− carbocycles with enhanced biopharmaceutical properties https://t.co/mrUa1SvNgW
NEW #ASAP by Steven Bloom & Samuel Gary @ChemKu
New work out from the Mo Lab in Nature Chemistry, “Biosynthesis-guided discovery reveals enteropeptins as alternative sactipeptides containing N-methylornithine.” Congratulations Brett, Kenzie, Mo! Paper: https://t.co/172HxjJGmV
#peptides#proteins#microbiome
We are very excited to share that our paper looking into @amanitin isomers has been published in @NatureComms! Have a look at why we suggest to call the isomer pairs #ansamers here
Open access:
👉https://t.co/AH3yB0s5PX
Happy to share our study that just published in Nature Communications about the discovery of novel cyclic peptides that modulate the activity of Lys63-linked ubiquitin chains in DNA repair https://t.co/7nXxRBfp6G
I’m excited to share our work on the development of bacterial PROTACs acting against Mycobacterium tuberculosis :) Our "homo-BacPROTACs" are able to kill drug-resistant Mtb by inducing the degradation of ClpC1, an essential protein in mycobacteria.
https://t.co/89VPJSNTNv
This one brings an exhausted, contented smile. A true pandemic paper, delayed by lab shutdowns, international travel bans, and 'procrastination' in writing due to being head of teaching throughout the pandemic. But it's finally done! Congrats to Ameer and thanks to all.
In recent years, covalent molecules have become increasingly popular among drug developers for their potency and their ability, if designed properly, to bind selectively to their intended targets and shut them down for good. https://t.co/VzvbQsiHPX
mRNA display makes billions of macrocyclic peptides in one round (🤯) - dramatically impacting drug discovery.
@ACSMedChemLett highlights Merck’s PCSK9 inhibitor which is the first clinical candidate from this technology!
https://t.co/yvZFxi0M0f
A new paper from @kevansf and @bignerdzzy identified a strained β-lactone electrophile that covalently targets a KRAS G12 somatic 2 mutation and acylates the mutant serine to suppress oncogenic signaling.
Congrats to Simon Ng, Alex Brueckner, and team for this work just out in J Med Chem that identifies macrocyclic peptide ligands against STUB1 (aka Chip). These peptides serve as important starting points STUB1 inhibitors and/or target protein degraders. https://t.co/zG10RCSv1J
Is a third way for manufacturing peptides? Read out recently published review @ACSChemRev
Liquid-Phase Peptide Synthesis (LPPS): A Third Wave for the Preparation of Peptides https://t.co/LvI6ElkWEt
Property-Driven Development of Passively Permeable Macrocyclic Scaffolds Using Heterocycles (Yudin) @andrei_yudin@GeorgeJSaunders https://t.co/gg5PVTEWgK